PRESS RELEASE published on 09/25/2024 at 07:45, 1 month 26 days ago Press release: Orange intends to voluntarily delist from the NYSE, deregister with the SEC, and launch a consent solicitation in relation to certain outstanding notes Orange intends to delist from NYSE, deregister with SEC, and launch consent solicitation for outstanding notes. Maintaining ADR program and aiming at internal simplification and efficiency NYSE SEC Delist Orange Consent Solicitation
BRIEF published on 09/10/2024 at 22:05, 2 months 10 days ago Orange borrows 600 million euros on the bond market Bond Issue Fixed Rate Orange 600 Million Euros Maturity 2035
PRESS RELEASE published on 09/10/2024 at 22:00, 2 months 10 days ago Press release: Orange issues new bonds for a total notional of 600 million euros Orange issues new EUR 600 million bonds at 3.250% to strengthen balance sheet. Barclays, BBVA, J.P. Morgan, Natixis, Santander, and UniCredit are bookrunners Balance Sheet Barclays Bonds Orange Bookrunners
BRIEF published on 07/26/2024 at 15:27, 3 months 25 days ago Orange Releases 2024 Interim Financial Report Telecommunications Financial Report Transparency Orange 2024 Interim
PRESS RELEASE published on 07/26/2024 at 15:22, 3 months 25 days ago Orange: Publication of Orange’s 2024 interim financial report Orange has released its 2024 interim financial report, filed with AMF and SEC. Details on revenues, employees, and global presence included. Orange is a telecom leader Revenues Telecommunications Global Presence Financial Report Orange
PRESS RELEASE published on 07/24/2024 at 07:30, 3 months 28 days ago Press release Orange: first half 2024 results
BRIEF published on 07/03/2024 at 15:56, 4 months 17 days ago Société Générale crosses thresholds in the capital of ORANGE Voting Rights Société Générale Actions Crossing Thresholds Orange
BRIEF published on 06/21/2024 at 19:13, 4 months 29 days ago Orange Executes Share Buyback Transactions Share Buyback Treasury Shares 2024 Program Orange Long-term Incentive
PRESS RELEASE published on 06/21/2024 at 19:08, 4 months 29 days ago PR Orange: Transactions carried out as part of a share buyback program and outside of a liquidity contract Orange announces purchase of treasury shares for long-term incentive plans within the 2024 share buyback program. Details available on Orange website Euronext Paris Treasury Shares Buyback Program Orange Long-term Incentive Plans
BRIEF published on 06/17/2024 at 15:06, 5 months 3 days ago The BlackRock company falls below the 5% threshold in Orange Capital Actions BlackRock Crossing Threshold Orange
Published on 11/21/2024 at 13:30, 36 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 36 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 31 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 51 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 8 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 46 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
